A regularly updated website with all most recent clinical trials data in HCV infection
BACK TO HOMEPAGE
Clinical outcome after SVR: Veterans Affairs
Backus L, AASLD 2017, Abs. 78
Reduction in HCC risk after SVR: Veterans Affairs
Ioannou GN, AASLD 2017, Abs. 142
Incidence of HCC after HCV treatment with DAAs: ERCHIVES
Li DK. Hepatology 2018;67:2244-53
Clinical outcome after SVR: ANRS CO22 HEPATHER
Carrat F, AASLD 2017, Abs. LB-28
Survival benefit of DAA-induced SVR in patients with decompensated cirrhosis
Kim WR, AASLD 2017, Abs. LB-27
Survival benefit of DAA-induced SVR in patients with decompensated cirrhosis
Kim WR, EASL 2018, Abs. PS-151
Risk of non-hepatic cancer after HCV treatment
Chokkalingam AP, EASL 2018, Abs. PS-155
Impact of SVR on the extrahepatic manifestations of chronic HCV infection: meta-analysis
Cacoub P., Gut 2018;Epub ahead of print
